Gen-Probe Earnings Conference Call (Q3 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 29 Calls Today's Calls

Call Details Gen-Probe Earnings Conference Call (Q3 2009) Thu, Oct 29, 2009, 4:30 pm Eastern Listen to the archived event audio About Gen-Probe (NasdaqGS:GPRO) Gen-Probe Incorporated develops, manufactures, and markets nucleic acid probe-based products used for the clinical diagnosis of human diseases, and for screening donated human blood in North America and internationally. The company develops nucleic acid testing that enables detection of microorganisms. It markets a portfolio of products that use technologies to detect various infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia, and fungal infections. The company also offers blood screening products for the simultaneous detection of human immunodeficiency virus (type 1), hepatitis C virus, and procleix west nile virus. In addition, it sells TIGRIS instrument that enables blood collection centers to test donors’ blood. Further, the company develops and manufactures nucleic acid probe-based products for the detection of harmful organisms in the environment and in industrial processes. It markets and sells its clinical diagnostic products through distributors and direct sales force, as well as other products through collaborative partners. The company’s customers include reference laboratories, public health institutions, and hospitals. It has a collaboration agreement with Novartis Vaccines and Diagnostics, Inc. for the research, development, and manufacturing of its blood screening products. Gen-Probe Incorporated was founded in 1983 and is based in San Diego, California. More Info: Quote | Chart | News | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings